Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Simultaneous Versus Sequential Administration of mRNA COVID-19 Vaccine and Inactivated Influenza Vaccine (IIV) in Pregnant Women

NCT06503900 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT06503900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06503900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Simultaneous Versus Sequential Administration of mRNA COVID-19 Vaccine and Inactivated Influenza Vaccine (IIV) in Pregnant Women
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Completed
Start date
September 12, 2024
Completion date
November 19, 2025
Enrollment
98 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

adverse event following immunization, birth outcomes, safety